Found: 24
Select item for more details and to access through your institution.
FDA Updates Policies to Continue Gains in New Drug Approvals.
- Published in:
- 2015
- By:
- Publication type:
- Opinion
First-in-class approval rate stays steady.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 653, doi. 10.1038/nrd4119
- Publication type:
- Article
Generic Drugs Making Waves.
- Published in:
- Applied Clinical Trials, 2012, v. 21, n. 11, p. 12
- By:
- Publication type:
- Article
Around the world in a month.
- Published in:
- 2012
- Publication type:
- Quotation
2011 AAPS Annual Meeting and Exposition KEYNOTE SPEAKER.
- Published in:
- Pharmaceutical Research, 2011, v. 28, n. 8, p. 2055, doi. 10.1007/s11095-011-0509-3
- Publication type:
- Article
Avastin's Uncertain Future in Breast Cancer Treatment.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 6, p. 458, doi. 10.1093/jnci/djr088
- By:
- Publication type:
- Article
Conflicts and collaborations.
- Published in:
- 2010
- Publication type:
- Editorial
Reduce use of long-acting β2-agonists in asthma therapy, FDA says.
- Published in:
- American Journal of Health-System Pharmacy, 2010, v. 67, n. 7, p. 504, doi. 10.2146/news100024
- By:
- Publication type:
- Article
FDA finalizes rules on accessing experimental drugs.
- Published in:
- American Journal of Health-System Pharmacy, 2009, v. 66, n. 18, p. 1596, doi. 10.2146/news090074
- By:
- Publication type:
- Article
Conflict of interest and resignation at drug agency.
- Published in:
- Nature, 2009, v. 460, n. 7258, p. 943, doi. 10.1038/460943e
- Publication type:
- Article
Tainted weight-loss products.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2009, v. 180, n. 9, p. 917, doi. 10.1503/cmaj.090580
- By:
- Publication type:
- Article
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 120, doi. 10.1038/clpt.2008.265
- By:
- Publication type:
- Article
FDA Faces Challenges and Changes.
- Published in:
- Applied Clinical Trials, 2009, v. 18, n. 1, p. 26
- By:
- Publication type:
- Article
DIA Adds More History to Boston.
- Published in:
- 2008
- By:
- Publication type:
- Proceeding
Orphan Drug Act passes quarter-century milestone in fight against rare diseases.
- Published in:
- American Journal of Health-System Pharmacy, 2008, v. 65, n. 13, p. 1205, doi. 10.2146/news080054
- By:
- Publication type:
- Article
Surveillance Becomes More Active.
- Published in:
- 2008
- By:
- Publication type:
- Proceeding
CDER Gains Permanent Chief.
- Published in:
- Applied Clinical Trials, 2008, v. 17, n. 4, p. 22
- By:
- Publication type:
- Article
FDA encourages genetics-aided warfarin dosing.
- Published in:
- American Journal of Health-System Pharmacy, 2007, v. 64, n. 19, p. 1994, doi. 10.2146/news070085
- By:
- Publication type:
- Article
Is it possible to make a Cox-2 inhibitor that's safe?
- Published in:
- Nature Medicine, 2007, v. 13, n. 6, p. 653, doi. 10.1038/nm0607-653b
- Publication type:
- Article
FDA to Modernize BIMO Activities.
- Published in:
- Applied Clinical Trials, 2006, v. 15, n. 8, p. 24
- By:
- Publication type:
- Article
Search for Stability at FDA.
- Published in:
- 2005
- By:
- Publication type:
- Editorial
Critical Path Initiative: A Conversation with Janet Woodcock, MD.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 53
- By:
- Publication type:
- Article
Janet Woodcock discusses the role of the FDA in improving pharma productivity.
- Published in:
- 2004
- Publication type:
- Interview
FDA Director Explains the Changes.
- Published in:
- Bio-IT World, 2003, v. 2, n. 4, p. 64
- By:
- Publication type:
- Article